• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Arteris Inc.

    9/16/24 4:00:55 PM ET
    $AIP
    Semiconductors
    Technology
    Get the next $AIP alert in real time by email
    8-K
    false 0001667011 0001667011 2024-09-13 2024-09-13

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (date of earliest event reported): September 13, 2024

     

     

    ARTERIS, INC.

    (Exact name of Registrant, as specified in its charter)

     

     

     

    Delaware   001-40960   27-0117058
    (State or other jurisdiction
    of incorporation)
     

    (Commission

    File Number)

      (I.R.S. Employer
    Identification Number)

     

    900 E. Hamilton Avenue Suite 300

    Campbell, CA

      95008
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (408) 470-7300

    Former name or former address, if changed since last report: N/A

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Common Stock, $0.001 par value per share   AIP   The Nasdaq Stock Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On September 13, 2024, the Board of Directors (the “Board”) of Arteris, Inc. (the “Company”) upon the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”), approved Joachim Kunkel to be appointed to the Board effective September 16, 2024. Mr. Kunkel was appointed as a Class II director and as a member of the Compensation Committee. Mr. Kunkel’s term as director will expire at the 2026 annual meeting of stockholders or until his successor is elected and qualified or his earlier death, resignation, disqualification, retirement or removal.

    Mr. Kunkel most recently served as General Manager of the Intellectual Property (IP) business unit at Synopsys, Inc., a publicly-traded software company. Prior to becoming general manager in 2006, Mr. Kunkel served in various positions of increasing responsibility at Synopsys since 1994. Before joining Synopsys, Mr. Kunkel was co-founder of CADIS GmbH in Aachen, Germany. There, he served as Managing Director and performed duties related to engineering, sales, and marketing. Before co-founding CADIS, Mr. Kunkel was a research assistant at the Aachen University of Technology, where he conducted research in system-level simulation techniques for digital signal processing, with special emphasis on parallel computing. Mr. Kunkel holds a M.S.E.E. degree from the Aachen University of Technology.

    Pursuant to the Company’s non-employee director compensation program, as a non-employee director, Mr. Kunkel will receive (i) a $57,500 annual retainer for his service on the Board and Compensation Committee, prorated for the remainder of 2024, and (ii) an initial restricted stock unit (“RSU”) award covering an amount of shares of the Company’s common stock (the “Common Stock”) equal to $300,000 divided by the 30 day average stock price of the Company’s Common Stock on the date of the award grant, which will be September 16, 2024. The foregoing description is qualified in its entirety by reference to the text of the Company’s non-employee director compensation program, the form of which was filed as Exhibit 10.18 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission (the “SEC”) on October 18, 2021.

    Mr. Kunkel has no relationships requiring disclosure under Item 404(a) of Regulation S-K. Mr. Kunkel is not a party to any arrangement or understanding with any other person pursuant to which he was selected as a director.

    In addition, Mr. Kunkel will enter into the Company’s standard indemnification agreement for directors and executive officers, the form of which was filed as Exhibit 10.19 to the Company’s Registration Statement on Form S-1 filed with the SEC on October 18, 2021.

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: September 16, 2024

     

    By:  

    /s/ Nick B. Hawkins

    Name:   Nick B. Hawkins
    Title:   Chief Financial Officer
    Get the next $AIP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIP

    DatePrice TargetRatingAnalyst
    8/6/2025$12.00 → $15.00Buy
    TD Cowen
    9/1/2023$11.00 → $12.00Outperform
    TD Cowen
    3/4/2022$32.00 → $23.00Outperform
    Cowen
    11/22/2021$27.00Outperform
    Northland Capital
    11/22/2021$24.00Market Perform
    BMO Capital Markets
    11/22/2021$30.00Outperform
    Cowen
    11/22/2021$33.00Buy
    Jefferies
    11/22/2021$35.00Buy
    Rosenblatt
    More analyst ratings

    $AIP
    SEC Filings

    View All

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    1/7/26 4:26:46 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    1/6/26 4:26:21 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form 144 filed by Arteris Inc.

    144 - Arteris, Inc. (0001667011) (Subject)

    1/2/26 4:32:32 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP and General Counsel Alpern Paul L exercised 5,000 shares at a strike of $0.56 and sold $77,376 worth of shares (5,000 units at $15.48) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    2/4/26 4:58:24 PM ET
    $AIP
    Semiconductors
    Technology

    President and CEO Janac K Charles sold $318,974 worth of shares (17,884 units at $17.84) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    1/20/26 5:21:46 PM ET
    $AIP
    Semiconductors
    Technology

    Large owner Bayview Legacy, Llc sold $318,974 worth of shares (17,884 units at $17.84) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    1/20/26 5:21:22 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Buy and set a new price target of $15.00 from $12.00 previously

    8/6/25 7:10:46 AM ET
    $AIP
    Semiconductors
    Technology

    TD Cowen reiterated coverage on Arteris with a new price target

    TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously

    9/1/23 7:31:29 AM ET
    $AIP
    Semiconductors
    Technology

    Cowen reiterated coverage on Arteris with a new price target

    Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $23.00 from $32.00 previously

    3/4/22 7:21:31 AM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arteris to Announce Financial Results for the Fourth Quarter and Year End 2025 on Thursday, February 12, 2026

    CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A liv

    2/2/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Announces New Employment Inducement Grants

    CAMPBELL, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the compensation committee of the company's board of directors has granted an aggregate of 477,208 restricted stock units (RSUs) to 25 newly hired employees as inducement awards under the company's 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4). The effective RSU grant date was January 15, 2026 and it was approved by the company's board of directors. About Arteris Arteris is a leading provider of semiconductor technology that accelerates t

    1/16/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Closes Acquisition of Cycuity

    CAMPBELL, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it has closed its previously announced acquisition of Cycuity, Inc., a leading provider and domain expert of semiconductor cybersecurity assurance technology. Semiconductor cybersecurity assurance is becoming critical to all types of chip designs, as the threat landscape has expanded to the hardware layer. Silicon vulnerabilities can result in compromised systems exposing unprotected information, a trend accelerated by the proliferation of AI and chiplets. Reported new Common Vulnerabilities and Exposures (CVEs

    1/14/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Leadership Updates

    Live Leadership Updates

    View All

    Joachim Kunkel Joins Arteris Board of Directors

    CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys' IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where

    9/16/24 5:00:00 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Arteris Inc.

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    11/13/24 4:32:26 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G filed by Arteris Inc.

    SC 13G - Arteris, Inc. (0001667011) (Subject)

    6/27/24 3:46:24 PM ET
    $AIP
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by Arteris Inc. (Amendment)

    SC 13G/A - Arteris, Inc. (0001667011) (Subject)

    1/24/24 4:05:55 PM ET
    $AIP
    Semiconductors
    Technology

    $AIP
    Financials

    Live finance-specific insights

    View All

    Arteris to Announce Financial Results for the Fourth Quarter and Year End 2025 on Thursday, February 12, 2026

    CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865 Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A liv

    2/2/26 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2025 Guidance

    CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of semiconductor system IP for accelerating system-on-chip (SoC) creation, today announced financial results for the third quarter ended September 30, 2025 and provided estimated fourth quarter and updated full year 2025 guidance. "In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history," said K. Charles Janac, President and CEO of Ar

    11/4/25 4:06:00 PM ET
    $AIP
    Semiconductors
    Technology

    Arteris to Announce Financial Results for the Third Quarter 2025 on Tuesday, November 4, 2025

    CAMPBELL, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Tuesday, November 4, 2025. Management will host a conference call on Tuesday, November 4, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: United States/Canada Toll Free:+1-800-717-1738International Toll:+1-646-307-1865     Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be availabl

    10/23/25 4:05:00 PM ET
    $AIP
    Semiconductors
    Technology